Abstract:Background Fistulae represent a frequent complication in Crohn's disease (CD).Surgical resection is often required, as medical treatment outcome with conventional drugs is often insufficient.We have previously demonstrated that epithelial-to-mesenchymal transition (EMT) plays a critical role for fistula development.The T cell cytokines tumor necrosis factor (TNF), interleukin (IL)-13, interferon (IFN) g, IL-17A and IL-22 are highly expressed in transitional cells along fistula tracts in CD patients.Similar to transforming growth factor (TGF) b, TNF is able to induce EMT and the expression of molecules being associated with cell invasiveness and migration.IL-13 has no impact on epithelial cell morphology, but also induces expression of genes being associated with invasive cell growth, such as SLUG transcription factor and b6-integrin.Here, we analyzed the implication of the T cell-derived cytokines IFNg, IL-17A and IL-22 in the event of EMT.Moreover, we investigated if there are differences in the composition of lymphocytes in the blood of CD patients suffering from fistulae compared to patients without fistulae or healthy controls.Methods Threedimensional intestinal epithelial cell (IEC) constructs (spheroids) were stimulated with IFN g, IL-17A and IL-22 to investigate the effects on EMT development.Further, CD4+ and CD25+ T cells were isolated from fistulizing CD patients' blood or control blood samples and cocultured together with HT29 cells.Afterwards, mRNA expression levels of EMT-associated genes were analyzed.Results Treatment of the in vitro spheroid model with IFNg resulted in a loss of the well-defined globular spheroid shape after day 7.We observed a clear separation of IECs, while mRNA levels for EMT-related transcription factors like SNAIL-1 and ETS-1 were not up-regulated.IL-17A and IL-22 had no effect on cell morphology suggesting that they do not induce EMT in our cell model.On a molecular level, both cytokines had no effect on the mRNA expression of EMT-associated genes, but prevented the TGFb-induced up-regulation of e.g.SNAIL-1 or ETS-1.The sorting of T cells isolated from blood of CD patients with fistulae revealed an elevated expression level of CD4+ and CD25+ T cells compared to healthy controls.Conclusions Our data demonstrate that T cell derived cytokines may play a crucial role in the pathogenesis of CD-associated fistulae.Th1 cell-derived IFNg may be involved in the event of EMT in IECs, however Th17 cellderived cytokines IL-17A and IL-22 are likely not implicated in EMT onset, and may prevent EMT-associated effects of TGFb.This observation supports the hypothesis that Th17 cellderived cytokines exert a pivotal role for maintaining intestinal homeostasis.The different lymphocyte composition in CD patients' blood represents a further hint for the importance of these cells in fistulae formation.

Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis

P146 Latent activation of the extrinsic coagulation pathway in patients with ulcerative colitis

Tissue factor-dependent colitogenic CD4+ T cell thrombogenicity is regulated by activated protein C signalling

Identification of Crucial Genes and Related-Transcription Factors in Ulcerative Colitis

TLR2 promotes traumatic deep venous thrombosis of the lower extremity following femoral fracture by activating the NF‑κB/COX‑2 signaling pathway in rats

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

Sa1852 Computational Prediction and Validation of UPF1 As a Novel Molecule for Ulcerative Colitis

Endothelial PTP1B Deletion Promotes VWF Exocytosis and Venous Thromboinflammation

Predictive value for increased activated factor XI activity in acute venous thromboembolism

Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation

Mechanism of Ulcerative Colitis-Aggravated Liver Fibrosis: The Activation of Hepatic Stellate Cells and TLR4 Signaling Through Gut-Liver Axis

Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation

New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology

P124 Tissue Factor and Protease-Activated Receptor 2 associated genes are upregulated in patients with Inflammatory Bowel Disease

Tissue factor at the crossroad of coagulation and cell signaling

The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis

P336 Exploring Extracellular Matrix Markers in Ulcerative Colitis: Degradation and Formation Insights

Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH

Procoagulant platelet activation promotes venous thrombosis

P204 Utility of Rotational Thrombo-Elastometry as an Objective Measure of Hypercoagulability in Patients with Ulcerative Colitis-A Prospective Case Control Study